Search results
Revolution Medicines Inc (RVMD) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
GuruFocus.com via Yahoo Singapore Finance· 2 months agoCash and Investments: Ended Q1 2024 with $1.7 billion, down from $1.85 billion at end of 2023. Net Loss: Reported $116.0 million for Q1 2024, or $0.70 per share. R&D Expenses: $118.0 million ...